Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Sun Pharmaceut Sun Pharmaceutical Industries Ltd. | BSE 1702.30 -1.70 (-0.10%) | NSE 1702.60 -1.80 (-0.11%) | Trade | Add

BSE Live

Feb 05, 16:01

1702.30 -1.70 (-0.10%)

Volume

AVERAGE VOLUME

5-Day

269,645

10-Day

193,480

30-Day

168,776

56,835

NSE Live

Feb 05, 15:57

1702.60 -1.80 (-0.11%)

Volume

AVERAGE VOLUME

5-Day

4,306,092

10-Day

3,807,641

30-Day

2,783,402

3,074,842

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.)	Mar 05	Mar 04
Per Share Ratios
Basic EPS (Rs.)	21.72	30.27
Diluted EPS (Rs.)	21.72	30.27
Cash EPS (Rs.)	24.14	34.44
Book Value [ExclRevalReserve]/Share (Rs.)	61.74	87.19
Book Value [InclRevalReserve]/Share (Rs.)	61.74	87.19
Revenue from Operations/Share (Rs.)	63.97	106.15
PBDIT/Share (Rs.)	25.32	44.18
PBIT/Share (Rs.)	23.13	41.10
PBT/Share (Rs.)	22.43	41.10
Net Profit/Share (Rs.)	21.95	31.36
NP After MI And SOA / Share (Rs.)	21.72	30.27
Profitability Ratios
PBDIT Margin (%)	39.57	41.61
PBIT Margin (%)	36.15	38.71
PBT Margin (%)	35.06	38.71
Net Profit Margin (%)	34.31	29.54
NP After MI And SOA Margin (%)	33.95	28.51
Return on Networth/Equity (%)	35.68	35.07
Return on Capital Employed (%)	14.25	29.07
Return on Assets (%)	12.13	18.43
Total Debt/Equity (X)	1.61	0.52
Asset Turnover Ratio (%)	0.49	0.00
Liquidity Ratios
Current Ratio (X)	6.09	3.27
Quick Ratio (X)	5.07	2.07
Inventory Turnover Ratio (X)	1.30	0.00
Dividend Payout Ratio (NP) (%)	17.26	21.47
Dividend Payout Ratio (CP) (%)	15.68	19.49
Earnings Retention Ratio (%)	82.74	78.53
Cash Earnings Retention Ratio (%)	84.32	80.51
Coverage Ratios
Interest Coverage Ratios (%)	36.30	--
Interest Coverage Ratios (Post Tax) (%)	36.30	--
Valuation Ratios
Enterprise Value (Cr.)	9,405.06	6,370.74
EV/Net Operating Revenue (X)	7.92	6.47
EV/EBITDA (X)	20.02	15.55
MarketCap/Net Operating Revenue (X)	7.37	6.12
Retention Ratios (%)	82.73	78.52
Price/BV (X)	7.74	7.53
Price/Net Operating Revenue	7.37	6.12
Earnings Yield	0.05	0.05